Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	17.62	89.93	76.46
Graham Fair Price	-23.95	24.49	32.20
PEG	237.43	-1.18	0.35
Price/Book	10.84	3.03	2.73
Price/Cash Flow	2575.23	2057.29	76.90
Prices/Earnings	93.26	50.42	26.09
Price/Sales	15.81	15.18	13.11
Price/FCF	2575.23	2057.29	76.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.63	0.37	0.36
Operating Margin	3.19	0.10	0.10
ROA	-41.80	< 0.005	0.02
ROE	0.03	0.02	-42.64
ROIC	0.02	0.01	-39.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.05	-87.34
Dividends QOQ	< 0.005	0.10	1733.14
EBIT QOQ	0.10	< 0.005	-90.95
EPS QOQ	0.75	-0.43	-42.73
FCF QOQ	0.21	-0.96	362.22
Revenue QOQ	0.02	-0.04	98.37
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	67.27	73.00	8.52
Days Sales Outstanding (DSO)	68.71	72.65	5.73
Inventory Turnover	1.34	1.23	-7.85
Debt/Capitalization	0.19	0.19	-0.77
Quick Ratio	1.20	1.11	-7.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	41.97	42.15	0.41
Cash	4.21	3.91	-6.95
Capex	-0.39	-0.31	21.18
Free Cash Flow	1.49	0.06	-95.84
Revenue	8.74	8.40	-3.89
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.76	1.67	-5.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.60	3.97	10.46
Naive Interpretation	Member

06 - Financial Health · Weak

Rating